Disease Insights and Burden in Metastatic Triple Negative Breast Cancer Market
Metastatic triple negative breast cancer (mTNBC) is considered one of the most challenging breast cancer subtypes due to the absence of key receptors, including estrogen, progesterone, and HER2. This makes conventional targeted and hormonal therapies ineffective, leaving limited treatment choices for patients. The...
SPARK Website
عربي